You are here

BioVaxys Technology Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
BIOV
CSE Index: 
CSE Composite
Currency: 
CAD

BioVaxys Technology Corp. is a British Columbia-registered biopharmaceuticals company based in Ontario, Canada that is developing BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© 'neoantigen' tumor cell construct platform for treating refractive late stage ovarian cancer. BioVaxys is also exploring vaccines for additional cancers and infectious diseases based on its HapTenix©platform through academic and other collaborations.

BioVaxys Technology Corp. (BIOV)

0.055 Up
0.005 (10.00%)

BioVaxys Technology Corp. (BIOV)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Quote

Bid Size
18,000 
Bid Price
0.05 
Ask Price
0.055 
Ask Size
71,000 
Volume
9,000 
Last Price
0.055 
Tick
Up 
Net Change
0.005 
Prev Close
0.05 
Open
0.055 
Day High
0.055 
Day Low
0.055 
52 Week High
0.09 
52 Week Low
0.04 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
20,000 
Bid Price
0.04 
Ask Price
0.00 
Ask Size
Volume
Last Price
0.045 
Tick
Up 
Net Change
 
Prev Close
0.045 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quote

Bid Size
18,000 
Bid Price
0.05 
Ask Price
0.055 
Ask Size
71,000 
Volume
9,000 
Last Price
0.055 
Tick
Up 
Net Change
0.005 
Prev Close
0.05 
Open
0.055 
Day High
0.055 
Day Low
0.055 
52 Week High
0.09 
52 Week Low
0.04 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
20,000 
Bid Price
0.04 
Ask Price
0.00 
Ask Size
Volume
Last Price
0.045 
Tick
Up 
Net Change
 
Prev Close
0.045 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Depth Display By Order

Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
TD Securities Inc. 2,000 0.05 0.055 68,000 Anonymous
Anonymous 12,000 0.05 0.055 3,000 TD Securities Inc.
Anonymous 4,000 0.05 0.06 10,000 TD Securities Inc.
CIBC World Markets Inc. 50,000 0.045 0.06 60,000 CIBC World Markets Inc.
CIBC World Markets Inc. 100,000 0.045 0.06 1,000 National Bank Financial Inc.
W.D. Latimer Co. Limited 10,000 0.045 0.06 1,000 National Bank Financial Inc.
National Bank Financial Inc. 11,000 0.045 0.06 1,000 National Bank Financial Inc.
TD Securities Inc. 2,000 0.045 0.06 26,000 National Bank Financial Inc.
TD Securities Inc. 20,000 0.045 0.065 4,000 National Bank Financial Inc.
National Bank Financial Inc. 4,000 0.045 0.065 80,000 Aviso Financial Inc.
Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
Anonymous 20,000 0.04 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Depth Display By Price

Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
3 18,000 0.05 0.055 71,000 2
7 197,000 0.045 0.06 99,000 6
10 255,000 0.04 0.065 156,000 16
6 110,000 0.035 0.07 298,000 8
2 75,000 0.03 0.075 2,105,000 4
Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
1 20,000 0.04 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Recent Trades

Date/Time Price Change Volume Buyer Seller Venue
Mar 19, 16:34 0.055 0.005 4,000 National Bank Financial Inc. Anonymous CSE
Mar 19, 15:38 0.055 0.005 2,000 National Bank Financial Inc. National Bank Financial Inc. CSE
Mar 19, 15:38 0.055 0.005 3,000 National Bank Financial Inc. Anonymous CSE
Mar 18, 19:38 0.05 0.00 3,000 Anonymous Anonymous CSE
Mar 18, 19:38 0.05 0.00 2,000 TD Securities Inc. Anonymous CSE

Company Info

Address
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Phone
646-452-7000
Email
jpassin@biovaxys.com
Website
https://biovaxys.com/
Listing date
Wednesday, November 21, 2018
Transfer Agent
Odyssey Trust Company
Email
news@biovaxys.com
Auditor
Dale Matheson Carr-Hilton Labonte LLP

SEDAR Information

Filing Type Any News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Phone
646-452-7000
Email
jpassin@biovaxys.com
Website
https://biovaxys.com/
Listing date
Wednesday, November 21, 2018
Transfer Agent
Odyssey Trust Company
Email
news@biovaxys.com
Auditor
Dale Matheson Carr-Hilton Labonte LLP

Capitalization

Issued & Outstanding: 
291525203
Reserved for Issuance: 
139701394

Company Officers

James Passin, CEO
Kenneth Kovan, COO & President
Christopher Cherry, Chief Financial Officer
James Passin, Chief Executive Officer
Christopher Cherry, Chief Financial Officer
Kenneth Kovan, Chief Operating Officer and President

Bulletins

16/07/2024

2024-0715 - Reinstatement - BioVaxys Technology Corp. (BIOV)

le 16 juillet/July 2024

Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

____________________________

Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.

La Société a rectifié la situation qui a donné lieu à la suspension.